Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Consume Fat Quick: 10 Demonstrated Activities for Ideal Outcomes - 2NASA releases stunning first images of Earth taken by the Artemis II astronauts
- 3IVE 2026 'Show What I Am' Tour: How to get tickets, prices, dates and more
- 4Soldiers seize power in Guinea-Bissau and detain the president
- 5Staggering Spots to Stargaze All over the Planet
- These 2 companies are teaming up to offer insurance for space debris strikes on satellites
- Flight cancellations: Full list of 40 airports hit by FAA cuts amid government shutdown
- Shelby County deputies charged with assault, placed on leave
- The Developing Nearby Food Development and Its Advantages
- How a Middle East War Becomes a Retail Price Hike
- Vote In favor of Your #1 Method for diminishing Pressure
- Iran’s Crown Prince Reza Pahlavi backs protests: Join your fellow citizens in the streets
- China's Normal Ponders: A Visual Excursion
- the 6 Shrewd Beds for seniors: A Complete Survey
